The new expert panelBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1510 (Published 02 December 1995) Cite this as: BMJ 1995;311:1510
- Trisha Greenhalgh, general practitioner
One of the advertised highlights at a recent conference of the British Diabetic Association was an expert panel discussion on hypoglycaemic unawareness. The subject had all the features needed to attract a packed and attentive audience—a clinical problem which is common, simple to conceptualise, and potentially fatal; a complex and hotly disputed physiological cause; controversy about a definition and even about the key symptoms; rumour that a cure was around the corner; and speculation, widely reported in the popular press, that a pharmaceutical industry cock-up (the introduction of human insulin) was the explanation for an alleged increase in incidence.
The first of the experts, a consultant physician, outlined the …